News Samsung Bioepis signs R&D agreement with Takeda South Korean firm looking to develop novel drugs
News Takeda begins new R&D link-up with Molecular Templates Takeda is increasing its R&D investment in oncology with a collaboration with Texas biotech Molecular Templates.
News Seattle, Takeda aim for first line Adcetris use Seattle CEO hopes Adcetris will be standard of care.
News AZ highlights data from next-gen oncology drugs at ASCO Tesara and Takeda among other companies to publish data.
News GW close to filing cannabis-based epilepsy drug Epidiolex could become a blockbuster if approved in all uses.
News Takeda signs deal with UK biotech GammaDelta Therapeutics on... UK biotech pioneering new type of T cell immunotherapy
News Repligen builds in cell therapy with $1.5bn BioLife takeover Repligen has reached a deal to buy cell therapy specialist BioLife Solutions for $1.5bn, tapping into a market growing at breakneck speed.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
